Contemporary and future invasive coronary vasomotor function testing and treatment in patients with ischaemia with no

Peter Damman1, Suzette E Elias-Smale1, Tijn P J Jansen1

  • 1Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Insights

This review highlights the crucial role of diagnostics and therapy for patients with ischaemia with no obstructive coronary arteries (INOCA). It details the coronary function test (CFT) and future diagnostic and treatment strategies for INOCA.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Ischaemia with no obstructive coronary arteries (INOCA) presents diagnostic challenges.
  • Accurate diagnosis and effective therapy are vital for managing INOCA patients.

Purpose of the Study:

  • To review the importance of diagnostics and therapy in INOCA.
  • To discuss the diagnostic coronary function test (CFT) and its future advancements.
  • To outline current and future treatment strategies for INOCA.

Main Methods:

  • Review of current literature on INOCA diagnostics and therapeutics.
  • Description of the diagnostic coronary function test (CFT) procedure.
  • Discussion of emerging technologies like angiography-derived physiology and invasive continuous thermodilution.

Main Results:

  • The coronary function test (CFT) is a key diagnostic procedure for INOCA.
  • Future diagnostic tools will enhance the understanding and identification of INOCA phenotypes.
  • Comprehensive treatment strategies are essential for improving patient outcomes.

Conclusions:

  • Effective INOCA management requires a focus on both diagnostics and therapy.
  • Advancements in diagnostic procedures like CFT are crucial for personalized INOCA care.
  • National registration and further research into pathophysiology will improve INOCA understanding and treatment.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
15
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
19
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
32